478 COM701 in combination with BMS-986207 (anti-TIGIT antibody) and nivolumab – preliminary results of safety, tolerability and pharmacokinetics in patients with advanced solid tumors (NCT04570839)

Authors :: Inbal Barbiro
Amita Patnaik
Manish Sharma
Drew Rasco
Ryan Sullivan
Ecaterina Dumbrava
Pierre Ferre
Gini Fleming
Kyriakos Papadopoulos
Daniel Vaena
Adam ElNaggar
Adeboye Adewoye
Robina Smith
Emerson Lim
Source :: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Publication Year :: 2021
Publisher :: BMJ Publishing Group, 2021.

Subjects :: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Full Text Access

Tools